Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns
Crossref DOI link: https://doi.org/10.1007/s11060-016-2306-7
Published Online: 2016-10-21
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Indini, Alice
Schiavello, Elisabetta
Biassoni, Veronica
Bergamaschi, Luca
Magni, Maria Chiara
Puma, Nadia
Chiaravalli, Stefano
Pallotti, Federica
Seregni, Ettore
Diletto, Barbara
Pecori, Emilia
Gandola, Lorenza
Poggi, Geraldina
Massimino, Maura
License valid from 2016-10-21